Literature DB >> 10215919

The effect of microglia on embryonic dopaminergic neuronal survival in vitro: diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective.

R Zietlow1, S B Dunnett, J W Fawcett.   

Abstract

When embryonic dopaminergic neurons are transplanted into the adult brain, approximately 95% die within a few days. To assess whether microglia activated during transplantation might be responsible for this rapid death, we examined the effect of microglia on rat embryonic dopaminergic neurons in vitro. Conditioned medium from 7-day-old microglia was found to decrease the number of dopamine neurons surviving in primary culture, but activation of the microglia with N-formyl-methionyl-leucyl-phenylalanine (FMLP) or Zymosan A did not increase the toxicity of the conditioned medium. We next tested the effect of coculturing microglia and dopaminergic neurons by placing microglia in semipermeable well inserts over the neuronal cultures. The presence of microglia now increased dopaminergic neuronal survival, microglial activation again having no effect. To increase yet further the possible interactions between microglia and neurons, the mesencephalic cells and microglia were mixed together and placed as a tissue in three-dimensional culture, and here again the presence of microglia increased dopaminergic neuronal survival with no effect of activation. Contact of microglia with the mesencephalic cells therefore converted them from being toxic to dopaminergic neurons to promoting their survival. The change in microglial effect from toxic to protective was caused by soluble molecules secreted by cells in the neuronal cultures, as conditioned medium derived from microglia-neuronal cocultures also had a dopaminergic neuron survival effect, indicating that microglia in cocultures behave differently from microglia removed from neuronal and glial influence. Microglia cocultured with either neurons or astrocytes downregulated inducible nitric oxide synthase (iNOS), indicating a decrease in the production of nitric oxide and possibly other toxic molecules. These findings indicate that in their natural environment, microglia are likely to be beneficial for the survival of embryonic dopaminergic grafts.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10215919     DOI: 10.1046/j.1460-9568.1999.00583.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  10 in total

Review 1.  Neuroinflammation and microglia: considerations and approaches for neurotoxicity assessment.

Authors:  Gaylia Jean Harry; Andrew D Kraft
Journal:  Expert Opin Drug Metab Toxicol       Date:  2008-10       Impact factor: 4.481

2.  Blockade of gap junction hemichannel protects secondary spinal cord injury from activated microglia-mediated glutamate exitoneurotoxicity.

Authors:  Daisuke Umebayashi; Atsushi Natsume; Hideyuki Takeuchi; Masahito Hara; Yusuke Nishimura; Ryuichi Fukuyama; Naoyuki Sumiyoshi; Toshihiko Wakabayashi
Journal:  J Neurotrauma       Date:  2014-09-23       Impact factor: 5.269

Review 3.  The role of astroglia on the survival of dopamine neurons.

Authors:  María Angeles Mena; Sonsoles de Bernardo; Maria José Casarejos; Santiago Canals; Eulalia Rodríguez-Martín
Journal:  Mol Neurobiol       Date:  2002-06       Impact factor: 5.590

4.  A novel role for Sema3A in neuroprotection from injury mediated by activated microglia.

Authors:  Henry H Majed; Siddharthan Chandran; Simone P Niclou; Richard S Nicholas; Alastair Wilkins; Mark G Wing; Kate E Rhodes; Maria Grazia Spillantini; Alastair Compston
Journal:  J Neurosci       Date:  2006-02-08       Impact factor: 6.167

5.  Proteomic Analysis of the Spatio-temporal Based Molecular Kinetics of Acute Spinal Cord Injury Identifies a Time- and Segment-specific Window for Effective Tissue Repair.

Authors:  Stephanie Devaux; Dasa Cizkova; Jusal Quanico; Julien Franck; Serge Nataf; Laurent Pays; Lena Hauberg-Lotte; Peter Maass; Jan H Kobarg; Firas Kobeissy; Céline Mériaux; Maxence Wisztorski; Lucia Slovinska; Juraj Blasko; Viera Cigankova; Isabelle Fournier; Michel Salzet
Journal:  Mol Cell Proteomics       Date:  2016-06-01       Impact factor: 5.911

6.  Time of transplantation and cell preparation determine neural stem cell survival in a mouse model of Huntington's disease.

Authors:  Verena Johann; Johannes Schiefer; Christian Sass; Jörg Mey; Gary Brook; Alexander Krüttgen; Christiane Schlangen; Christian Bernreuther; Melitta Schachner; Marcel Dihné; Christoph M Kosinski
Journal:  Exp Brain Res       Date:  2006-09-30       Impact factor: 2.064

7.  Blockade of gap junction hemichannel suppresses disease progression in mouse models of amyotrophic lateral sclerosis and Alzheimer's disease.

Authors:  Hideyuki Takeuchi; Hiroyuki Mizoguchi; Yukiko Doi; Shijie Jin; Mariko Noda; Jianfeng Liang; Hua Li; Yan Zhou; Rarami Mori; Satoko Yasuoka; Endong Li; Bijay Parajuli; Jun Kawanokuchi; Yoshifumi Sonobe; Jun Sato; Koji Yamanaka; Gen Sobue; Tetsuya Mizuno; Akio Suzumura
Journal:  PLoS One       Date:  2011-06-21       Impact factor: 3.240

8.  Microglia-Secreted Factors Enhance Dopaminergic Differentiation of Tissue- and iPSC-Derived Human Neural Stem Cells.

Authors:  Sissel Ida Schmidt; Helle Bogetofte; Louise Ritter; Jette Bach Agergaard; Ditte Hammerich; Amina Arslanagic Kabiljagic; Agnieszka Wlodarczyk; Silvia Garcia Lopez; Mia Dahl Sørensen; Mie Lærkegård Jørgensen; Justyna Okarmus; Alberto Martínez Serrano; Bjarne Winther Kristensen; Kristine Freude; Trevor Owens; Morten Meyer
Journal:  Stem Cell Reports       Date:  2021-01-21       Impact factor: 7.765

9.  Microglial VPAC1R mediates a novel mechanism of neuroimmune-modulation of hippocampal precursor cells via IL-4 release.

Authors:  Robert Nunan; Harri Sivasathiaseelan; Damla Khan; Malik Zaben; William Gray
Journal:  Glia       Date:  2014-05-06       Impact factor: 7.452

Review 10.  Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases.

Authors:  Hideyuki Takeuchi; Akio Suzumura
Journal:  Front Cell Neurosci       Date:  2014-09-02       Impact factor: 5.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.